← Leaderboards
Robert E Ratner
Medstar Research Institute
$8,754,185
Attributed
$8,754,185
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–11$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$8,754,185 · 5
By mechanism
U01$8,644,686 · 2
M01$109,499 · 3
Top collaborators
No co-investigators on record.
Most similar at Medstar Research Institute
Same institution · by research overlap
- David C Robbins$3,867,148
Others in their field
Top investigators on “Metformin”
- David M Nathan · Massachusetts Institute Of Technology$131,567,540
- John M Lachin · George Washington University$118,921,924
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Sarah E. Fowler · George Washington University$37,648,866
- Jose A Luchsinger · Columbia University Health Sciences$37,118,016
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
MetforminCardiovascular Disorder RiskFundingClinical TrialsIncidenceInsulin Sensitivity /ResistanceDisease /Disorder Prevention /ControlNoninsulin Dependent Diabetes MellitusRisk FactorsAtherosclerosisDiabetes MellitusCardiovascular DiseasesPreventLifestyle InterventionLong-Term EffectsImpaired Glucose ToleranceHuman SubjectPharmaceutical PreparationsDiabetes Prevention ProgramControlled Clinical TrialsCooperative StudyDesignGlucose ToleranceCohort
Grant awards (17)
Diabetes Prevention Program Outcomes Study - Phase 2$594,249
U01 · FY2011 · DK · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$387,019
U01 · FY2010 · DK · contact PI
Diabetes Prevention Program Outcomes Study - Phase 2$616,860
U01 · FY2009 · DK · contact PI
THE METFORMIN-EXENATIDE-INSULIN (MEXELIN) TRIAL$50,936
M01 · FY2009 · RR · contact PI
Long Term DPP Follow-Up Study$577,433
U01 · FY2008 · DK · contact PI
THE METFORMIN-EXENATIDE-INSULIN (MEXELIN) TRIAL$27,824
M01 · FY2008 · RR · contact PI
Long Term DPP Follow-Up Study$400,317
U01 · FY2007 · DK · contact PI
Stop Atherosclerosis in Native Diabetics study (SANDS)$197,305
U01 · FY2007 · HL · contact PI
Stop Atherosclerosis in Native Diabetics study (SANDS)$2,074,057
U01 · FY2006 · HL · contact PI
Long Term DPP Follow-Up Study$491,792
U01 · FY2006 · DK · contact PI
Long Term DPP Follow-Up Study$183,550
U01 · FY2005 · DK
INHALED INSULIN USING THE AERX IDMS VS SC INSULIN VIA SY$30,739
M01 · FY2005 · RR
Long Term DPP Follow-Up Study$428,635
U01 · FY2004 · DK
Long Term DPP Follow-Up Study$428,635
U01 · FY2003 · DK
DIABETES PREVENTION PROGRAM$456,689
U01 · FY2002 · DK
DIABETES PREVENTION PROGRAM$696,021
U01 · FY2001 · DK
DIABETES PREVENTION PROGRAM$1,112,124
U01 · FY2000 · DK